PureTech to Present at Two Upcoming Investor Conferences

BusinesswireOct 30 07:00 ET

PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

BusinesswireOct 21 02:00 ET

Correction to Old Drug Repurposed Article on Oct. 7 -- WSJ

WSJOct 9 14:09 ET

PureTech Health Eyes New IPF Treatment Horizon

TipRanksOct 1 07:08 ET

PureTech to Present at CHEST 2024 Annual Meeting

Business WireOct 1 07:00 ET

Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades

BenzingaSep 27 07:56 ET